Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is NEVIRAPINE ANHYDROUS USP (PROCESS II), with a corresponding US DMF Number 24520.
Remarkably, this DMF maintains an Active status since its submission on January 17, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 01, 2015, and payment made on April 09, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II